Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Dave Clark

Minimally-invasive prostate cancer treatment used by Jeremy Clarkson has fewer side effects

  • A new study has revealed that minimally-invasive focal therapy for prostate cancer , a treatment used by Jeremy Clarkson and Lord David Cameron , offers comparable effectiveness to traditional radiotherapy and prostatectomy surgery .
  • Research from Imperial College London, published in European Urology, found that only two out of nearly 3,500 men died from prostate cancer a decade after undergoing focal therapy, demonstrating excellent long-term cancer control similar to conventional treatments.
  • The innovative approach specifically targets and destroys only cancerous tissue, resulting in a five-fold lower risk of severe side effects such as urinary incontinence, erectile dysfunction and rectal problems compared to traditional methods.
  • Prostate cancer is the most common cancer in men in the UK, with an estimated 15,000 cases annually being suitable for focal therapy, representing 50-66 per cent of localised diagnoses.
  • The UK Government recently announced extra funding to expand the provision of focal therapy, as currently only about 1,000 men per year receive the treatment despite its suitability for a much larger patient group.

IN FULL

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.